Progentec, a leader in the development of nextgen diagnostics and digital therapeutics for the management of autoimmune diseases, has completed a $5 million Series A funding round led by Plains Venture Partners, the Oklahoma Seed Capital Fund and the Oklahoma Angel Capital Fund II, managed by i2E Management Company (Oklahoma City), with participation from NMC…